2012
DOI: 10.1016/j.bbi.2012.09.001
|View full text |Cite
|
Sign up to set email alerts
|

Postnatal administration of IL-1Ra exerts neuroprotective effects following perinatal inflammation and/or hypoxic-ischemic injuries

Abstract: New therapeutic strategies are needed to protect neonates, especially premature newborns, against brain injury and associated neurobehavioral deficits. The role of pro-inflammatory cytokines, especially IL-1β, in the pathophysiological pathway leading to neonatal brain damage is increasingly recognized and represents an attractive therapeutic target. We investigated the therapeutic potential of postnatal systemic administration of the interleukin (IL)-1 receptor antagonist (IL-1Ra) in an animal model of perina… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

11
84
2

Year Published

2013
2013
2022
2022

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 97 publications
(97 citation statements)
references
References 65 publications
11
84
2
Order By: Relevance
“…To our knowledge, our group is the first to show that NACA reduces the cerebral concentration of IL-1β after neonatal hypoxia. This could indicate that NACA has some positive effects; previous studies have shown that IL-1β is upregulated after cerebral ischemia and that anakinra, an IL1 receptor antagonist, has some neuroprotective abilities [24,25]. …”
Section: Discussionmentioning
confidence: 99%
“…To our knowledge, our group is the first to show that NACA reduces the cerebral concentration of IL-1β after neonatal hypoxia. This could indicate that NACA has some positive effects; previous studies have shown that IL-1β is upregulated after cerebral ischemia and that anakinra, an IL1 receptor antagonist, has some neuroprotective abilities [24,25]. …”
Section: Discussionmentioning
confidence: 99%
“…Animal models have shown rhIL-1ra to result in decreased loss of neurons at the cerebral cortex, region CA3 of the hippocampus and the dentate hilus following TBI as well as reduction in overall lesion size (Sanderson et al, 1999;Toulmond and Rothwell, 1995). RhIL-1ra is shown to attenuate hypoxic insults in animals in addition to preserving neuronal stem cells and white matter integrity (Girard et al, 2012). Additionally, rhIL-1ra has beneficial effects in limiting neuronal loss due to excitotoxicity (Lawrence et al, 1998).…”
Section: Interleukin -1 Receptor Antagonistmentioning
confidence: 95%
“…In addition to a direct neurotoxic effect of infection/inflammation, several studies have demonstrated that LPS or poly(I:C) can sensitize the brain to subsequent injury following hypoxia-ischemia [65,97]. This increased vulnerability of the neonatal brain to LPS has been attributed to IL-1β [98]. It is important to appreciate that the bacterial mimics and inflammatory agents used in these postnatal rodent models may not replicate the full repertoire of inflammatory responses observed following infection.…”
Section: Postnatal Infection/inflammation In Rodentsmentioning
confidence: 99%